company background image
SHTD.Y logo

Sinopharm Group OTCPK:SHTD.Y Stock Report

Last Price

US$13.32

Market Cap

US$8.3b

7D

5.8%

1Y

-23.2%

Updated

24 Apr, 2024

Data

Company Financials +

Sinopharm Group Co. Ltd.

OTCPK:SHTD.Y Stock Report

Market Cap: US$8.3b

SHTD.Y Stock Overview

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China.

SHTD.Y fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Sinopharm Group Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinopharm Group
Historical stock prices
Current Share PriceHK$13.32
52 Week HighHK$18.01
52 Week LowHK$11.36
Beta0.83
1 Month Change2.35%
3 Month Change4.88%
1 Year Change-23.18%
3 Year Change-13.28%
5 Year Change-31.85%
Change since IPO-39.56%

Recent News & Updates

Recent updates

Shareholder Returns

SHTD.YUS HealthcareUS Market
7D5.8%2.1%1.2%
1Y-23.2%3.6%24.7%

Return vs Industry: SHTD.Y underperformed the US Healthcare industry which returned 3.6% over the past year.

Return vs Market: SHTD.Y underperformed the US Market which returned 24.7% over the past year.

Price Volatility

Is SHTD.Y's price volatile compared to industry and market?
SHTD.Y volatility
SHTD.Y Average Weekly Movement4.7%
Healthcare Industry Average Movement7.2%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: SHTD.Y has not had significant price volatility in the past 3 months.

Volatility Over Time: SHTD.Y's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003115,959Yong Liuwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.

Sinopharm Group Co. Ltd. Fundamentals Summary

How do Sinopharm Group's earnings and revenue compare to its market cap?
SHTD.Y fundamental statistics
Market capUS$8.32b
Earnings (TTM)US$1.25b
Revenue (TTM)US$82.34b

6.7x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SHTD.Y income statement (TTM)
RevenueCN¥596.57b
Cost of RevenueCN¥548.06b
Gross ProfitCN¥48.51b
Other ExpensesCN¥39.46b
EarningsCN¥9.05b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)2.90
Gross Margin8.13%
Net Profit Margin1.52%
Debt/Equity Ratio57.0%

How did SHTD.Y perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

30%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.